COMPANY

Mirimus, Inc.

HQ: Brooklyn, NY source · mirimus.com ↗ · Mid-Atlantic

Mirimus is a preclinical CRO that builds genetically engineered animal and cell models using gene editing and RNAi for in vivo studies and preclinical testing. From company website Source · Oct 12, 2026

Keywords: CRO preclinical gene editing RNAi animal models

Location: Brooklyn, NY · source · Oct 15, 2026

Profile checked Oct 10, 2026

8NIH grants

NIH awards 8

Annual award amounts. Total $4.6M.

Sep 20, 2024 NIH award 1R43GM154496-01A1 FY2024: $350,000 awarded for that fiscal year; activity R43 (SBIR); PI PREMSRIRUT, PREM KHOVABUTR; recipient as written: MIRIMUS, INC., Brooklyn, NY. Creation of the Next Generation RNAi T source ↗
May 10, 2023 NIH award 1R41CA278070-01A1 FY2023: $397,916 awarded for that fiscal year; activity R41 (STTR); PI PREMSRIRUT, PREM KHOVABUTR; recipient as written: MIRIMUS, INC., Brooklyn, NY. Preclinical Evaluation of a Novel ADAM source ↗
May 4, 2021 NIH award 5R44OD026184-03 FY2021: $1,011,479 awarded for that fiscal year; activity R44 (SBIR); PI PREMSRIRUT, PREM KHOVABUTR; recipient as written: MIRIMUS, INC., Brooklyn, NY. CRISPR/Cas-mediated development of an source ↗
May 7, 2020 NIH award 2R44OD026184-02 FY2020: $1,020,397 awarded for that fiscal year; activity R44 (SBIR); PI PREMSRIRUT, PREM KHOVABUTR; recipient as written: MIRIMUS, INC., Brooklyn, NY. CRISPR/Cas-mediated development of an source ↗
Jul 31, 2018 NIH award 1R43OD026184-01 FY2018: $234,510 awarded for that fiscal year; activity R43 (SBIR); PI PREMSRIRUT, PREM KHOVABUTR; recipient as written: MIRIMUS, INC., Brooklyn, NY. High efficiency platform for rapid RNAi source ↗
Mar 15, 2018 NIH award 5R44CA188154-03 FY2018: $751,587 awarded for that fiscal year; activity R44 (SBIR); PI PREMSRIRUT, PREM KHOVABUTR; recipient as written: MIRIMUS, INC., Brooklyn, NY. Next generation CRISPR/Cas9-RNAi mouse m source ↗
Apr 6, 2017 NIH award 2R44CA188154-02 FY2017: $656,563 awarded for that fiscal year; activity R44 (SBIR); PI PREMSRIRUT, PREM KHOVABUTR; recipient as written: MIRIMUS, INC., Brooklyn, NY. Next generation CRISPR/Cas9-RNAi mouse m source ↗
Aug 4, 2014 NIH award 1R43CA188154-01 FY2014: $189,010 awarded for that fiscal year; activity R43 (SBIR); PI FELLMANN, CHRISTOF; recipient as written: MIRIMUS, INC., Brooklyn, NY. RNA interference - genetically engineered mouse source ↗